Tanezumab reduces osteoarthritis knee pain, phase II study finds
Friday, October 1, 2010 - 22:21
in Health & Medicine
Just months after a pharmaceutical company halted studies of tanezumab, a drug used in reducing pain and improving function in people with moderate-to-severe osteoarthritis of the knee, the results of a small, phase II clinical trial found only a few minor side effects and substantial improvement in patient conditions.